Alecensa (Alectinib) 150mg Capsules | Roche Taiwan China for ALK+ NSCLC | GLT

Generic Information: Alecensa (Alectinib) — Taiwan, China Version

The Taiwan, China presentation of Alecensa brings Roche's alectinib 150 mg capsules to buyers who specifically want this regulated-market pack. Taiwan, China was among the earlier Asia-Pacific health systems to fund alectinib through its national health insurance program, which means the packs circulating there move through one of the tighter quality loops in the region — regulatory review, hospital tendering and pharmacovigilance all in one channel. For GLT customers the practical pull is straightforward: genuine Roche capsules, regional labeling, and supply that does not depend on the US channel.

What Is Alecensa (Alectinib) Used For?

Clinicians across Taiwan, China and the wider region prescribe alectinib for ALK-rearranged locally advanced or metastatic non-small cell lung cancer — first choice at diagnosis and after crizotinib failure — with national guidelines tracking the global preference for second-generation ALK inhibition up front. The intracranial rationale weighs heavily in this region: East Asian ALK-positive populations show heavy brain-metastasis burden at presentation, and alectinib's CNS penetration directly answers it. Adjuvant use after resection of node-positive or larger tumors is referenced as it is worldwide, always on the back of a documented ALK test.

How Does Alecensa (Alectinib) Work?

Alectinib blocks the ALK fusion kinase that ALK-rearranged tumors depend on — retaining activity against common crizotinib-resistance mutations — and additionally inhibits RET kinase as a laboratory target. Two pharmacologic traits define its clinical personality: strong blood-brain barrier penetration (it is not pumped back out by P-gp/BCRP), and an active metabolite, M4, that doubles the ALK blockade. Both parent and metabolite have half-lives in the thirty-hour range, smoothing out twice-daily dosing, and food substantially boosts absorption.

Indications of Alecensa (Taiwan, China)

The regional label follows the international template: ALK-positive metastatic NSCLC as initial therapy; continued use after crizotinib progression or intolerance; and adjuvant treatment after complete resection of ALK-positive tumors of 4 cm or larger or with nodal involvement, per the practice-changing ALINA programme. A validated ALK-positive result precedes every one of these uses — no test, no therapy.

Dosage and Administration

Every eight hours the schedule resets, but the constant is 600 mg twice daily: four 150 mg capsules with the morning meal, four with the evening meal — 1,200 mg a day total. Child-Pugh C liver impairment begins at 450 mg twice daily. Reductions step down by 150 mg per dose; failure to tolerate 300 mg twice daily ends treatment. Capsules are never opened or dissolved; a forgotten dose is caught up unless the next is fewer than six hours away.

Side Effects of Alecensa (Alectinib)

Regional practice manages the familiar profile: constipation, ankle and periorbital swelling, myalgia, fatigue, anemia and rash day-to-day; liver-enzyme rises, interstitial lung disease, slow heart rate, CPK elevation with muscle injury, hemolytic anemia and photosensitivity as the sentinel events that trigger lab draws, ECGs and dose holds. Blood tests every two weeks through the early months, routine pulse and blood pressure checks, and aggressive sun protection are the standing instructions patients in the region receive with their first pack.

Storage Instructions

Keep the carton below 30°C, dry and shaded; blister strips in use stay within their labeled in-use period. No refrigeration is needed. Medicines stay out of children's reach, and expired capsules go back to a pharmacy for disposal rather than into household trash.

Why Choose Alecensa (Taiwan, China) from GLT?

GLT fields two honest questions from every alectinib enquirer — which pack, and at what cost. For buyers anchored to the Taiwan, China pack we source sealed Roche stock through verified channels with batch documentation; for buyers anchored to budget we show the same molecule from other regulated markets and from WHO-GMP generics in Bangladesh and Laos, which typically price out roughly 70%–80% below US list for the same month of therapy. Either way you see batch numbers before payment and deal with a named contact — WhatsApp +86 15234153837, [email protected] — not a ticket queue.

How to Order Alecensa (Alectinib)

Send your enquiry with product and quantity, get a written quotation with courier and payment options, confirm, and GLT ships with complete export documentation; institutional buyers can request CoA and batch photographs beforehand. WhatsApp +86 15234153837 and [email protected] are the two fastest lines — both are answered daily.

FAQ

Why pick the Taiwan, China pack over others? Regional labeling and regulated-market supply chains; the capsule inside is the same Roche alectinib.

Is alectinib reimbursed there? Yes — the national health insurance program funds it for eligible ALK-positive patients, which keeps the local channel well supplied.

Can GLT quote several versions together? Yes — we routinely compare US, India and Taiwan, China originator packs and the certified generics side by side.

Do you need my ALK test report? We ask for it as part of responsible supply — alectinib does nothing for ALK-negative disease.

How fast is dispatch? In-stock orders typically move within one to two working days of payment confirmation.